Categories
Change Password!
Reset Password!
A prospective interventional study was performed to investigate the efficacy of fluticasone nasal sprays in odour disorders and triamcinolone oral paste in taste dysfunction in individuals having laboratory-confirmed coronavirus disease 2019 (COVID-19).
A prospective interventional study
was performed to investigate the efficacy of fluticasone nasal sprays in odour
disorders and triamcinolone oral paste in taste dysfunction in individuals
having laboratory-confirmed coronavirus disease 2019 (COVID-19).
In
total, 120 patients diagnosed with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) (mean age 50.88 ± 15.93 years) were recruited. The
control group (mean age is 51.2 ± 14.89) did not receive any interventional
therapy and only supervision of the symptoms was carried out to evaluate the
recovery time. Testing was done on days one and five after proven infection by
reverse transcription-polymerase chain reaction test.
Following the usage of triamcinolone in the
mouth and fluticasone in the nose, substantial improvements were noted in
identifying all the smell and taste on day five in comparison with day one in
the case-cohort. During the comparison of smell and taste of cases vs. the
control group, either no improvement or deterioration in taste or smell on day
five in the control group was noted.
Using fluticasone nasal spray and
triamcinolone paste improves olfactory and taste functions respectively in
coronavirus-infected patients.
American Journal of Otolaryngology
The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients
Chandra Veer Singh et al.
Comments (0)